In this issue:
No survival benefit to lenvatinibpembrolizumab- chemo combo in GEJ cancer
Preliminary efficacy for novel antibody doublet in advanced ESCC
Depressive symptoms linked to poor survival in newly diagnosed EGC
Does prehabilitation blunt chemotherapy-associated muscle loss?
The prognostic value of CRM definition and location in oesophageal cancer
Prognostic value of TRG is dependent on type of neoadjuvant therapy
Risk factors for benign anastomotic stenosis after esophagectomy
PNI is a prognostic marker in ESSC treated with immunotherapy
Front-line ICI-based therapy effective for ESSC in real-world setting
Clinicopathological features of ESCC in patients with no major risk factors
Please login below to download this issue (PDF)